Connect with us

INDUSTRIAL HEMP

Omeros Corporation (NASDAQ:OMER) Finalizes Its OMS721 FDA submission and approval Clinical Plan

Published

on

Omeros Corporation (NASDAQ:OMER) announced about a week ago that it managed to complete its clinical plan for submission and approval of OMS721 after meeting with the FDA.

The announcement revealed that the company recently held a meeting with the U.S Food and Drug Administration, after which it completed OMS721 submission and approval clinical plan. Omero is seeking OMS721 submission and approval for immunoglobulin A nephropathy (IgAN). OMS721 is the company’s leading human monoclonal antibody which targets effector enzyme called MASP-2 in the lectin pathway. IgA nephropathy does not currently have any approved treatments.

The FDA received some of IgAN’s phase 2 clinical trial results as part of the material that was handed over during the meeting. The FDA meeting confirmed the extension of proteinuria’s phase 3 clinical trial’s primary endpoint from 24 to 36 weeks. The extension was issued after the company requested it along with extra OMS721 dosage if necessary.

The next big cannabis story to hit North America is Phoenix Life Science International (PLSI), traded in the US, but with the largest global production based in the tropics and a license to distribute worldwide. Take a look at Phoenix Life Science International PLSI), Its currently trading under $18 dollars per share on the OTC markets. Learn More Now!

OMS721 will be allowed open-label treatment but only after a minimum of one year of blinded treatment. This development is in response to the concerns expressed by investigators about extended OMS721 treatment withholding especially in high-risk study patients.

Omeros to sign up more patients in preparation for the OMS721 Phase 3 ARTEMIS-IGAN trials

Omeros plans to continue enrolling more patients in its OMS721 Phase 3 ARTEMIS-IGAN trials. However, it plans to do so without affecting the patients that are already enrolled in the study. The company will base the Phase 3 OMS721 clinical trials on the positive results that it collected from the Phase 2 cohorts.

“The data from the Phase 2 study continue to show a consistent and significant drug effect, the magnitude of which is unparalleled,” stated Professor Richard Lafayette who is the chairman of the OMS721 IgAN Academic Leadership Committee.

Professor Lafayette also pointed out that “Nephrologists target long-term kidney survival. He added that OMS721’s observed effects on eGFR and proteinuria are the results that the company expects to see. Omeros expects positive results from the OMS721 Phase 3 ARTEMIS-IGAN trial based on the consistent results that the firm has already seen in previous clinical trials.

Pushing the barriers for global distribution, Phoenix Life Science International (PLSI) is the next cannabis play. Just think Canopy x 100, that is how big their plantation in the tropics will be. No lights, no green houses, just maximum growth + minimal cost = home run. Learn More Now!

   

Learn More About PLSI at your brokerage today!

         
Continue Reading

TRENDING STORIES

INDUSTRIAL HEMP4 months ago

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) Acquires 46% Stake In Curative Cannabis And Agrees to Fund Cannabis Cultivation Facility To Produce Ultra Premium Cannabis

Auxly Cannabis Group Inc (OTCMKTS:CBWTF) has entered a deal to take over a 46% stake in Curative Cannabis. The company...

INDUSTRIAL HEMP4 months ago

Canntrust Holdings Inc. (OTCMKTS:CNTTF) Receive Permission From The Town Of Pelham For Their Third Phase Construction

CannTrust Holdings Inc. (OTCMKTS:CNTTF) has announced that they have obtained the required permit to go on with the third phase...

INDUSTRIAL HEMP4 months ago

Indiva Ltd (OTCMKTS:NDVAF) Announces 9.9% Equity Investment In Retailgo Inc.

Indiva Ltd (OTCMKTS:NDVAF) has announced that they are delighted to have finalized an Equity investment of 9.9% in RetailGo Inc....

INDUSTRIAL HEMP4 months ago

Future Farm Technologies Inc (OTCMKTS:FFRMF) Plans To Begin Selling Of Cheery Wine Strain Hemp Seeds And Test Operation Of The Oil Extraction Equipment

Future Farm Technologies Inc (OTCMKTS:FFRMF) is planning to commence the selling of the elite cherry Wine hemp seeds by putting...

INDUSTRIAL HEMP4 months ago

OrganiGram Holdings Inc (OTCMKTS:OGRMF) Sources Hemp With High Levels of CBD From 1812 Hemp

OrganiGram Holdings Inc (OTCMKTS:OGRMF) has entered into a supply pact with 1812 Hemp, an industrial hemp research company based in...

INDUSTRIAL HEMP4 months ago

Kona Gold Solutions Inc (OTCMKTS:KGKG) Declares That They Have Acquired Gold Leaf Distribution

Kona Gold Solutions Inc (OTCMKTS:KGKG) has announced the acquisition of Gold Leaf distribution a newly established distribution company. The Florida...

INDUSTRIAL HEMP4 months ago

CFN Media Group features Supreme Cannabis Company (OTCMKTS:SPRWF) as consideration for investors as their 2019 stock scales up

CFNB Media Group has announced a publication on Supreme Cannabis Company (OTCMKTS:SPRWF) as a licensed producer obsessed with quality. Supreme...

INDUSTRIAL HEMP4 months ago

Village Farms International Inc (OTCMKTS:VFFIF) Leading Greenhouse Crop Protection And Announces Plans To List Its Common Shares On The NASDAQ Market

Village Farms International Inc (OTCMKTS:VFFIF) has announced that they have facilitated Health Canada Pest Management Agency to get approval for...

INDUSTRIAL HEMP4 months ago

Sunniva Inc. (OTCMKTS:SNNVF) Secures More Funding For Growth Strategy As Plans Solidify Towards A Tremendous Year

Sunniva Inc. (OTCMKTS:SNNVF) is solidifying its growth strategy in anticipation for exponential growth this year. Notably, the firm acquired a...

INDUSTRIAL HEMP4 months ago

Curis, Inc. (NASDAQ:CRIS) Announce The Dosing Of The First Mesothelioma Patient In The First Phase Of The CA-170 Study

Curis, Inc. (NASDAQ:CRIS) has announced the enrolment and dosing of the first mesothelioma patient in the first phase of the...

Advertisement

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play